Welcome to our dedicated page for Fmc SEC filings (Ticker: FMC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
FMC Corporation filings document the regulatory record of a NYSE-listed agricultural sciences company with common stock trading under FMC. Recent 8-K reports disclose operating results, material credit-agreement amendments, financial covenants, subsidiary guarantees, collateral arrangements, dividend limitations, restructuring charges, and governance changes.
Proxy materials describe annual meeting matters, stockholder voting procedures, and equity incentive plan approvals. Together, the filings cover FMC's capital structure, board oversight, compensation programs, manufacturing footprint actions, risk-related covenant terms, and recurring financial reporting for its crop protection business.
FMC Corporation and certain subsidiaries entered into Amendment No. 7 to their Fifth Amended and Restated Credit Agreement originally dated June 17, 2022. The amendment changes the limitation on liens in the credit facility and releases security interests on certain collateral that previously secured the company’s obligations.
The agreement continues to involve Citibank, N.A. as administrative agent and a syndicate of lenders and issuing banks. Some of these lenders and their affiliates also provide FMC with other financial services, including cash management, investment banking, trust and leasing services, as well as interest rate and foreign exchange arrangements.
FMC Corporation entered into a framework agreement to sell underutilized buildings and land at its Stine Research Center campus in Newark, Delaware to Ercor Elkton, LLC for gross cash proceeds of approximately $114 million, subject to a due diligence period and other closing conditions and adjustments.
FMC plans to negotiate a leaseback so it can continue using the facilities it actively operates, aiming to minimize disruption to research operations and maintain core research activities and scientific infrastructure on site. The adjacent Maryland property will be retained. The transaction is expected to close in the fourth quarter and the proceeds are expected to be used to pay down debt, but the agreement is preliminary and may not result in a completed transaction.
FMC CORP Chairman, CEO and President Pierre R. Brondeau reported a tax-related share withholding on vested equity. On June 11, 2026, 34,177 shares of Common Stock were disposed of at $10.80 per share to cover tax liabilities on 74,314 shares that vested the same day. These vested shares were originally granted on June 11, 2024. Following this tax-withholding disposition, Brondeau directly holds 533,869 FMC shares.
FMC Corporation completed a private offering of $1.2 billion of 8.000% Senior Secured Notes due 2031. The notes were issued at 100% of principal and are senior secured obligations, guaranteed by various U.S. and international subsidiaries and secured by first‑priority liens on substantial company and subsidiary assets.
FMC expects net proceeds of about $1.185 billion, which it plans to use to repurchase or redeem its 3.200% Senior Notes due October 1, 2026, repay borrowings under its Fifth Amended and Restated Credit Agreement, and for general corporate purposes including repayment of other debt. The notes carry semi‑annual interest payments and include customary redemption, change‑of‑control repurchase and covenant protections for noteholders.
FMC Corporation has priced an offering of $1.2 billion aggregate principal amount of 8.000% senior secured notes due 2031 at an issue price of 100% of principal. The notes will be sold in a private offering under Rule 144A and Regulation S and are expected to close on June 5, 2026, subject to customary conditions.
FMC intends to use the net proceeds to fund the repurchase or redemption of its outstanding 3.200% Senior Notes due October 1, 2026, repay borrowings under its Fifth Amended and Restated Credit Agreement, and for general corporate purposes, including repayment of other debt. The notes will be fully and unconditionally guaranteed by various subsidiaries and secured by first-priority liens on substantially all specified assets and certain equity interests.
FMC Corporation plans a private offering of $750.0 million aggregate principal amount of senior secured notes due 2031. The company expects to sell these notes to qualified institutional buyers under Rule 144A and to certain non-U.S. investors under Regulation S.
FMC intends to use the net proceeds to repurchase or redeem its outstanding 3.200% Senior Notes due October 1, 2026, repay borrowings under its Fifth Amended and Restated Credit Agreement dated June 17, 2022, and for general corporate purposes, including repayment of other debt. The notes will be fully and unconditionally guaranteed by selected subsidiaries and secured by first-priority liens on specified assets and equity interests, subject to customary conditions and completion of the offering.
FMC CORP reported a Schedule 13G showing AQR Capital affiliates beneficially own 9,261,783 shares of common stock, representing 7.41% of the class. The filing lists 8,596,298 shares as shared voting power and states AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC.
Verduin Patricia reported acquisition or exercise transactions in this Form 4 filing.
FMC Corp director Patricia Verduin received a grant of 9,175 shares of FMC common stock on April 28, 2026. The shares were awarded at a price of $0.00 per share, indicating a compensation-related grant rather than an open-market purchase. Following this award, Verduin directly owns 16,326 FMC common shares.
FMC CORP director John Mitchell Raines received a grant of 9,175 shares of Common Stock on April 28, 2026. The shares were acquired as a grant or award at a stated price of $0.00 per share, increasing his direct holdings to 22,996 shares of FMC common stock.
FMC Corp director Robert C. Pallash reported a tax-related share disposition. On April 28, 2026, 18,843 shares of FMC common stock were used to satisfy a tax liability at an indicated value of $15.56 per share, classified as a tax-withholding disposition rather than an open-market sale. After this transaction, Pallash directly owned 41,827 shares of FMC common stock.